Tag: drug

Mabwell’s 9MW5211 Receives IND Clearance from NMPA for Inflammatory Bowel Disease

SHANGHAI, June 4, 2026 /PRNewswire/ -- Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that its independently developed innovative...

WuXi Biologics Singapore CRDMO Hub Completes Modular Topping-Out of Drug Product Facility

SINGAPORE, June 4, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has completed the...

Target Recalls Up & Up Fragrance Free and Fresh Cucumber Scented Baby Wipes Due to Potential Microbial Contamination

MINNEAPOLIS, June 4, 2026 /PRNewswire/ -- Target is voluntarily recalling Up & Up Fragrance Free and Up & Up Fresh Cucumber Scented Baby Wipes...

Laguna Treatment Center Warns of Concerning Increase in Patients Seeking Help for Kratom Addiction

Orange County addiction treatment center sees alarming rise in kratom dependence and warns of the risks.

Surgent CPE Launches New Health Savings Account CPE Series Taught by One of the Nation’s Foremost HSA Authorities

Three new NASBA-approved live webinar courses on Health Savings Accounts are now available from Roy Ramthun, who led the U.S. Treasury's implementation of HSAs...

NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters’ Option

Offering was led by B Group Capital with significant participation from, among others, Columbia Threadneedle Investments, Corbets Capital, Venture 76, and Mossrock Capital

Offering was led by B Group Capital with significant participation from, among others, Columbia Threadneedle Investments, Corbets Capital, Venture 76, and Mossrock Capital

Lundbeck presents positive Phase IIb data for bocunebart (Lu AG09222; anti-PACAP mAb) in migraine prevention at the AHS congress

The intravenous part of the Phase IIb clinical dose-finding trial PROCEED met its primary endpoint, with bocunebart demonstrating a statistically significant reduction in monthly...

Seven Arrows Recovery Expands Public Education Efforts Around Forward-Facing, Nervous System Centred Addiction Treatment

The Arizona residential treatment center introduces broader awareness of its trauma-informed and salutogenic recovery model through Forward-Facing® Accelerated Recovery

The Arizona residential treatment center introduces broader awareness of its trauma-informed and salutogenic recovery model through Forward-Facing® Accelerated Recovery

MAIA Biotechnology Reports Strong Enrollment and Dosing Momentum in Pivotal Phase 3 Non-Small Cell Lung Cancer Trial

MAIA’s novel telomere-targeting therapy being evaluated as a third-line treatment for advanced non-small cell lung cancer

PharmaBlock’s First Peptide GMP Pilot-scale Plant at PharmaBlock Zhejiang Site Now Operational

Next-Generation Peptide CRDMO Solutions Enabled by a Green and Intelligent Platform for Empowering Global Innovative Drug DevelopmentNANJING, China, June 4, 2026 /PRNewswire/ -- PharmaBlock Sciences (Stock...

Emergent BioSolutions Supports Victoria’s Voice Foundation’s National Naloxone Awareness Day to Help Save Lives from Opioid Overdose

Efforts focus on increasing awareness, expanding access to lifesaving NARCAN® Nasal Spray and reaching more communities with educational initiatives and resources

Efforts focus on increasing awareness, expanding access to lifesaving NARCAN® Nasal Spray and reaching more communities with educational initiatives and resources

HotSpot Therapeutics Presents Preclinical Data from Small Molecule IRF5 Inhibitor Program at EULAR 2026

BOSTON, June 4, 2026 /PRNewswire/ -- HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of oral, allosteric small molecules that target...

LIGHT AI ANNOUNCES INITIATION OF FDA PIVOTAL CLINICAL TRIAL FOR QUICKSCAN™ STREP A SOFTWARE AS A MEDICAL DEVICE (SaMD)

Ethics Committee Approval Received for Pivotal Study Intended to Support U.S. FDA Class II Submission for QuickScan™ Strep AVANCOUVER, BC, June 4, 2026 /CNW/...

World’s First CLDN18.2 ADC for Regulatory Review: Innovent Biologics Announces IBI343 (arcotatug tavatecan) Met Primary Endpoint in International Phase 3 Study in Advanced Refractory...

SAN FRANCISCO and SUZHOU, China, June 4, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Name

This field is for validation purposes and should be left unchanged.

HomeTagsDrug

Mabwell’s 9MW5211 Receives IND Clearance from NMPA for Inflammatory Bowel Disease

Iron Age Nutrition Announces Launch of “Sour Apple Crush” Flavor in Total Hydrate Electrolyte Line

UP Fintech Investor News: If You Have Suffered Losses in UP Fintech Holding Limited (NASDAQ: TIGR), You Are Encouraged to Contact The Rosen Law...

Tag: drug

Mabwell’s 9MW5211 Receives IND Clearance from NMPA for Inflammatory Bowel Disease

WuXi Biologics Singapore CRDMO Hub Completes Modular Topping-Out of Drug Product Facility

Target Recalls Up & Up Fragrance Free and Fresh Cucumber Scented Baby Wipes Due to Potential Microbial Contamination

Laguna Treatment Center Warns of Concerning Increase in Patients Seeking Help for Kratom Addiction

Surgent CPE Launches New Health Savings Account CPE Series Taught by One of the Nation’s Foremost HSA Authorities

NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters’ Option

Lundbeck presents positive Phase IIb data for bocunebart (Lu AG09222; anti-PACAP mAb) in migraine prevention at the AHS congress

Seven Arrows Recovery Expands Public Education Efforts Around Forward-Facing, Nervous System Centred Addiction Treatment

MAIA Biotechnology Reports Strong Enrollment and Dosing Momentum in Pivotal Phase 3 Non-Small Cell Lung Cancer Trial

PharmaBlock’s First Peptide GMP Pilot-scale Plant at PharmaBlock Zhejiang Site Now Operational

Emergent BioSolutions Supports Victoria’s Voice Foundation’s National Naloxone Awareness Day to Help Save Lives from Opioid Overdose

HotSpot Therapeutics Presents Preclinical Data from Small Molecule IRF5 Inhibitor Program at EULAR 2026

LIGHT AI ANNOUNCES INITIATION OF FDA PIVOTAL CLINICAL TRIAL FOR QUICKSCAN™ STREP A SOFTWARE AS A MEDICAL DEVICE (SaMD)

World’s First CLDN18.2 ADC for Regulatory Review: Innovent Biologics Announces IBI343 (arcotatug tavatecan) Met Primary Endpoint in International Phase 3 Study in Advanced Refractory...

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us